Levels of neuropeptides nocistatin, nociceptin/orphanin FQ and their precursor protein in a rat neuropathic pain model

Peptides

Volumn 28, Issue 7, 2007, Pages 1433-1440

  Joseph, Tessy ^a   Lee, Tat Leang ^a   Li, Chunmei ^a   Siau, Chiang ^a   Nishiuchi, Yuji ^b   Kimura, Terutoshi ^b   Tachibana, Shinro ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Peptide Institute Inc   (Japan)

Author keywords

Neuropathic pain; Nociceptin orphanin FQ; Nocistatin; Prepronociceptin; Radioimmunoassay

Indexed keywords

NEUROPEPTIDE; NOCICEPTIN; NOCISTATIN; PREPRONOCICEPTIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; RADIOIMMUNOASSAY; RAT; SCIATIC NERVE; SERUM; SPINAL CORD; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIBODIES; BRAIN; HYPERALGESIA; MALE; MODELS, ANIMAL; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SCIATIC NERVE; SPINAL CORD;

RATTUS;

EID: 34447644204     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.05.009     Document Type: Article

References (40)

1. Altier C., Khosravani H., Evans R.M., Hameed S., Peloquin J.B., Vartian B.A., et al. ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 9 (2006) 31-40
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
3. Briscini L., Corradini L., Ongini E., and Bertorelli R. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur J Pharmacol 447 (2002) 59-65
4. Chen Y., and Sommer C. Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing. J Peripher Nerv Sys 11 (2006) 232-240
5. Chen Y., and Sommer C. Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: Involvement of inflammatory mediators. J Neurosci Res 85 (2007) 1478-1488
6. Courteix C., Coudoré-Civiale M.A., Privat A.M., Pélissier T., Eschalier A., and Fialip J. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain 110 (2004) 236-245
7. Csullog E., Joo G., Toth G., Dobos I., Benedek G., and Horvath G. Antinociceptive effect of continuous intrathecal administration of endomorphin-1. Pain 94 (2001) 31-38
8. Dong X.W., Williams P.A., Jia Y.P., and Priestley T. Activation of spinal ORL-1 receptors prevents acute cutanious neurogenic inflammation: role of nociceptin-induced suppression of primary afferent depolarization. Pain 96 (2002) 309-318
9. Fiset M., Gilbert C., Poubelle P.E., and Pouliot M. Human Neutrophils as a source of nociceptin: A novel link between pain and inflammation. Biochemistry 42 (2003) 10498-10505
10. Fu X., Wang Y.-Q., Wang J., Yu J., and Wu G.-C. Changes in expression of nociceptin/orphanin FQ and its receptor in spinal dorsal horn during electroacupuncture treatment for peripheral inflammatory pain in rats. Peptides 28 (2007) 1220-1228
11. Gabriel A., Pletruck C., Sharma M., Palmer P.P., and Grond S. Regulation of spinal nociception expression by neuropathic pain. Anaesthetist 53 (2004) 621-628
12. Gordon I., Veeraindar G., and Edwin D. Novel pharmacologic options in the treatment of neuropathic pain. CNS Spectrums 9 (2004) 1-11
13. Jia Y., Linden D.R., Serie J.R., and Seybold V.S. Nociceptin/Orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation. Neurosci Lett 250 (1998) 21-24
14. Jimenez E.C., Donevan S., Walker C., Zhou L.M., Nielsen J., Cruz L.J., et al. Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency. Epilepsy Res 51 (2002) 73-80
15. Joseph T., Lee T.L., Ning C., Nishiuchi Y., Kimura T., Jikuya H., et al. Identification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLC. Peptides 27 (2006) 122-130
16. Kazi J.A., Liu E.H.C., Lee T.L., and Tachibana S. Localization of nocistatin-binding sites in mice brain and spinal cord using a biotinylated nocistatin probe. NeuroReport 18 (2007) 767-770
17. Ko M.H., Kim Y.H., Woo R.S., and Kim K.W. Quantitative analysis of nociceptin in blood of patients with acute and chronic pain. Neuroreport 13 (2002) 1631-1634
18. Lee T.L., Fung M.Y., Chen F.G., Chou N., Okuda-Ashitaka E., Ito S., et al. Identification of human, rat and mouse nocistatin in brain and human cerebrospinal fluid. NeuroReport 10 (1999) 1537-1541
19. Liu E.H.C., Nishiuchi Y., Kimura T., and Tachibana S. Supraspinal nocistatin and its amide derivative antagonize the hyperalgesic effects of nociceptin in mice. Neuroscience Lett 397 (2006) 59-63
20. Ma F., Xie H., Dong Z.Q., Wang Y.Q., and Wu G.C. Effect of intrathecal nocistatin on nociceptin/orphanin FQ analgesia in chronic constriction injury rat. Brain Res 988 (2003) 189-192
21. 1 mRNA in some brain nuclei in neuropathic pain rats. Brain Res 1043 (2005) 214-217
22. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53 (2001) 381-415
23. Mollereau C., and Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21 (2000) 907-917
24. Muth-Selbach U., Dybeck E., Kollosche K., Stegmann J.U., Holthusen H., Lipfert P., et al. The spinal antinociceptive effect of Nocistatin in neuropathic rats is blocked by D-serine. Anesthesiology 101 (2004) 753-758
25. Myers R.R., Campana W.M., and Shubayev V.I. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 11 (2006) 8-20
26. Nakagawa T., Kaneko M., Inamura S., and Satoh M. Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats. Neurosci Lett 265 (1999) 64-66
27. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., et al. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 392 (1998) 286-289
28. Pampusch M.S., Serie J.R., Osinki M.A., and Seybold V.S. Expression of nociceptin/OFA receptor and pre-pronociceptin. OFQ in lymphoid tissues. Peptides 21 (2000) 1865-1870
29. Petrosino S., Palazzo E., Novellis V., Bisogno T., Rossi F., Maione S., et al. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacol 52 (2007) 415-422
30. Petterson L.M., Sundler F., and Danielsen N. Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord. Brain Res 945 (2002) 266-275
31. Rizzi A., Nazzaro C., Marzola G.G., Zucchini S., Trapella C., Guerrini R., et al. Endogenous nociceptin/orphanin FQ signaling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences. Pain 124 (2006) 100-108
32. Rosen A., Lunderberg T., Bytner B., and Nylander I. Central changes in nociceptin dynorphin B and Met-enkephalin-Arg-Phe in different models of nociception. Brain Res 857 (2000) 212-218
33. Schuligoi R., Amann R., Angelberger P., and Peskar B.A. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neuroscience Lett 224 (1997) 136-138
34. Scoto G.M., Santangelo N., and Parenti C. Effect of supraspinal Nocistatin on Nociceptin/Orphanin FQ antagonism of selective opioid analgesia. Neuroscience Lett 387 (2005) 126-129
35. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
36. Sun R.Q., Wang Y., Zhao C.S., Chang J.K., and Han J.S. Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat neuropathic pain. Neurosci Lett 311 (2001) 13-16
37. Tekes K., Hantos M., and Csaba G. Single neonatal treatment with β-endorphin extreamingly enhances nocistatin level of cerebrospinal fluid in adult rats. Life Sci 74 (2004) 1993-1997
38. Walczak J.S., Pichette V., Leblond F., Desbiens K., and Beaulieu P. Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain. Neuroscience 132 (2005) 1093-1102
39. Zeilhofer H.U., and Calo G. Nociceptin/Orphanin FQ and its receptor-potential targets for pain therapy?. J Pharmacol Exp Ther 306 (2003) 423-429
40. Zhao C.S., Li B.S., Zhao G.Y., Liu H.X., Luo F., Wang Y., et al. Nocistatin reverses the effect of orphanin FQ/nociceptin in antagonizing morphine analgesia. Neuroreport 10 (1999) 297-300